Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Eichelbaum

Showing results (161-170 of 263) with videos related to

Pageof 27
Sort By:
Journal of Chromatography. B, Biomedical Sciences and Applications|June 9, 1999
Highly sensitive gas chromatographic-tandem mass spectrometric method for the determination of morphine and codeine in serum and urine in the femtomolar rangeU Hofmann, S Seefried, E Schweizer, et al.
Gastroenterology|August 7, 2001
Shortcoming in the diagnosis of TPMT deficiency in a patient with Crohn's disease using phenotyping onlyM Schwab, E Schaeffeler, C Marx, et al.
Molecular Pharmacology|January 1, 1993
Identification and characterization of the cytochrome P450 enzymes involved in N-dealkylation of propafenone: molecular base for interaction potential and variable disposition of active metabolitesS Botsch, J C Gautier, P Beaune, et al.
European Journal of Clinical Pharmacology|January 1, 1975
Bioavailability of m-octopamine in man related to its metabolismJ H Hengstmann, W Konen, C Konen, et al.
Verhandlungen Der Deutschen Gesellschaft Fur Innere Medizin|January 1, 1973
[Influence of thyroid function on human drug metabolism]R Gugler, M Eichelbaum, C Schneider-Deters, et al.
Journal of Cardiovascular Pharmacology|January 1, 1988
Pharmacokinetics and pharmacodynamics of nitrendipine in healthy subjects and patients with kidney and liver diseaseM Eichelbaum, G Mikus, V Mast, et al.
Pharmacology & Therapeutics|January 1, 1987
Influence of the enzyme induction by rifampicin on its presystemic metabolismU Loos, E Musch, J C Jensen, et al.
Pain|August 8, 1998
Same incidence of adverse drug events after codeine administration irrespective of the genetically determined differences in morphine formationK Eckhardt, S Li, S Ammon, et al.
The New England Journal of Medicine|May 9, 1974
Influence of thyroid status on plasma half-life of antipyrine in manM Eichelbaum, G Bodem, R Gugler, et al.
European Journal of Clinical Pharmacology|January 1, 1994
Rapid determination of CYP2D6 phenotype during propafenone therapy by analysing urinary excretion of propafenone glucuronidesS Botsch, G Heinkele, C O Meese, et al.
Pageof 27

Showing results (161-170 of 263) with videos related to

Sort By:
Pageof 27
Journal of Chromatography. B, Biomedical Sciences and Applications|June 9, 1999
Highly sensitive gas chromatographic-tandem mass spectrometric method for the determination of morphine and codeine in serum and urine in the femtomolar rangeU Hofmann, S Seefried, E Schweizer, et al.
Gastroenterology|August 7, 2001
Shortcoming in the diagnosis of TPMT deficiency in a patient with Crohn's disease using phenotyping onlyM Schwab, E Schaeffeler, C Marx, et al.
Molecular Pharmacology|January 1, 1993
Identification and characterization of the cytochrome P450 enzymes involved in N-dealkylation of propafenone: molecular base for interaction potential and variable disposition of active metabolitesS Botsch, J C Gautier, P Beaune, et al.
European Journal of Clinical Pharmacology|January 1, 1975
Bioavailability of m-octopamine in man related to its metabolismJ H Hengstmann, W Konen, C Konen, et al.
Verhandlungen Der Deutschen Gesellschaft Fur Innere Medizin|January 1, 1973
[Influence of thyroid function on human drug metabolism]R Gugler, M Eichelbaum, C Schneider-Deters, et al.
Journal of Cardiovascular Pharmacology|January 1, 1988
Pharmacokinetics and pharmacodynamics of nitrendipine in healthy subjects and patients with kidney and liver diseaseM Eichelbaum, G Mikus, V Mast, et al.
Pharmacology & Therapeutics|January 1, 1987
Influence of the enzyme induction by rifampicin on its presystemic metabolismU Loos, E Musch, J C Jensen, et al.
Pain|August 8, 1998
Same incidence of adverse drug events after codeine administration irrespective of the genetically determined differences in morphine formationK Eckhardt, S Li, S Ammon, et al.
The New England Journal of Medicine|May 9, 1974
Influence of thyroid status on plasma half-life of antipyrine in manM Eichelbaum, G Bodem, R Gugler, et al.
European Journal of Clinical Pharmacology|January 1, 1994
Rapid determination of CYP2D6 phenotype during propafenone therapy by analysing urinary excretion of propafenone glucuronidesS Botsch, G Heinkele, C O Meese, et al.
Pageof 27